Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 15/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.40 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.38 |
| ▸ | APP | P05067 | 8/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | CHUK | O15111 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976638 | 0.71 | BACE1 (0.56) | BACE1KCNH2BACE2APP | |
| SCHEMBL6891149 | 0.67 | BACE1 (0.58) | BACE1KCNH2BACE2APP | |
| SCHEMBL932719 | 0.66 | BACE1 (0.57) | BACE1KCNH2BACE2APP | |
| SCHEMBL932326 | 0.65 | BACE1 (0.56) | BACE1KCNH2BACE2APP | |
| SCHEMBL25006211 | 0.61 | MEN1 (0.49) | — | |
| SCHEMBL932205 | 0.61 | BACE1 (0.61) | BACE1KCNH2BACE2APP | |
| SCHEMBL931600 | 0.60 | BACE1 (0.55) | BACE1KCNH2BACE2APP | |
| SCHEMBL29403248 | 0.59 | ESR2 (0.52) | PGRARCHUK | |
| SCHEMBL6752587 | 0.59 | ESR2 (0.52) | PGRARCHUK | |
| SCHEMBL31589804 | 0.59 | ALDH1A1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011002408-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |